By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NanoString Technologies Inc. 

201 Elliott Avenue West
Suite 300
Seattle  Washington  98119  U.S.A.
Phone: 206-378-NANO Fax: 206-378-6288


SEARCH JOBS


Industry
Diagnostics






Company News
NanoString Technologies Inc. (NSTG) Announces Unexpected Death Of Chief Medical Officer, J. Wayne Cowens, MD 8/27/2014 8:30:44 AM
NanoString Technologies Inc. (NSTG) To Present At Upcoming Investor Conferences 8/21/2014 8:14:20 AM
NanoString Technologies Inc. (NSTG) Receives Market Approval From The Australian Therapeutic Goods Administration For Its Prosigna Breast Cancer Prognostic Gene Signature Assay 8/6/2014 10:05:49 AM
NanoString Technologies Inc. (NSTG) Releases Financial Results For Second Quarter Of 2014 8/5/2014 3:18:16 PM
NanoString Technologies Inc. (NSTG) Introduces New Universal Junction Probe Design For Detecting Gene Fusions 7/29/2014 10:10:00 AM
NanoString Technologies Inc. (NSTG), Celgene Corporation (CELG) Strike $45 Million Companion Diagnostic Pact 6/3/2014 5:00:15 PM
NanoString Technologies Inc. (NSTG) Receives Canadian Market Approval For Its Prosigna Breast Cancer Prognostic Gene Signature Assay 5/7/2014 8:42:05 AM
NanoString Technologies Inc. (NSTG) Introduces Novel PanCancer Gene Expression Panel For Multiplexed Pathway Analysis 4/7/2014 10:06:08 AM
NanoString Technologies Inc. (NSTG) Release: Newly Published Analytical Validation Study Shows Precision And Reproducibility Of PAM50-Based Prosigna Breast Cancer Assay In Multiple Clinical Testing Laboratories 3/14/2014 8:56:01 AM
NanoString Technologies Inc. (NSTG) Release: Study Confirms Ability Of The Prosigna Assay To Assess Risk Of Late Distant Recurrence In Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer 2/12/2014 8:05:06 AM
123456789
//-->